Oral Semaglutide
-
{
- All
- News
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
- Thursday May 14, 2026
- Health | Written by Sambhav Kumar
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
www.ndtv.com
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
- Saturday April 18, 2026
- Lifestyle | Written by Krati Purwar
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
www.ndtv.com/lifestyle
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
- Thursday May 14, 2026
- Health | Written by Sambhav Kumar
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
www.ndtv.com
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
- Saturday April 18, 2026
- Lifestyle | Written by Krati Purwar
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
www.ndtv.com/lifestyle
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
- Monday February 9, 2026
- Health | Written by Tanushka Dutta
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
www.ndtv.com